Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Croft

Showing results (251-260 of 356) with videos related to

Pageof 36
Sort By:
The American Journal of Cardiology|December 13, 2000
Comparison of four echocardiographic techniques for measuring left ventricular ejection fractionT Nahar, L Croft, R Shapiro, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
Cascade degradation and upcycling of polystyrene waste to high-value chemicalsZhen Xu, Fuping Pan, Mengqi Sun, et al.
Bioorganic & Medicinal Chemistry|June 10, 2004
Synthesis and antileishmanial activity of novel buparvaquone oxime derivativesAntti Mäntylä, Jarkko Rautio, Tapio Nevalainen, et al.
Journal of Medicinal Chemistry|December 13, 2005
Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfideSeheli Parveen, Mohammed O F Khan, Susan E Austin, et al.
Planta Medica|July 26, 2000
Bioactive compounds from Celaenodendron mexicanumM R Camacho, R Mata, P Castaneda, et al.
Biomedical Chromatography : BMC|January 22, 2008
Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic studyGantala Venkatesh, M I A Majid, S Ramanathan, et al.
Phytochemistry|February 24, 2001
Terpenoids from Guarea rhophalocarpaM del Rayo Camacho, J D Phillipson, S L Croft, et al.
International Journal of Antimicrobial Agents|July 14, 2007
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivoKarin Seifert, F Javier Pérez-Victoria, Marianne Stettler, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin BMalika Larabi, Vanessa Yardley, Philippe M Loiseau, et al.
Plos Neglected Tropical Diseases|March 2, 2021
Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasisAndrew A Voak, Andy Harris, Jose Miguel Coteron-Lopez, et al.
Pageof 36

Showing results (251-260 of 356) with videos related to

Sort By:
Pageof 36
The American Journal of Cardiology|December 13, 2000
Comparison of four echocardiographic techniques for measuring left ventricular ejection fractionT Nahar, L Croft, R Shapiro, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
Cascade degradation and upcycling of polystyrene waste to high-value chemicalsZhen Xu, Fuping Pan, Mengqi Sun, et al.
Bioorganic & Medicinal Chemistry|June 10, 2004
Synthesis and antileishmanial activity of novel buparvaquone oxime derivativesAntti Mäntylä, Jarkko Rautio, Tapio Nevalainen, et al.
Journal of Medicinal Chemistry|December 13, 2005
Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfideSeheli Parveen, Mohammed O F Khan, Susan E Austin, et al.
Planta Medica|July 26, 2000
Bioactive compounds from Celaenodendron mexicanumM R Camacho, R Mata, P Castaneda, et al.
Biomedical Chromatography : BMC|January 22, 2008
Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic studyGantala Venkatesh, M I A Majid, S Ramanathan, et al.
Phytochemistry|February 24, 2001
Terpenoids from Guarea rhophalocarpaM del Rayo Camacho, J D Phillipson, S L Croft, et al.
International Journal of Antimicrobial Agents|July 14, 2007
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivoKarin Seifert, F Javier Pérez-Victoria, Marianne Stettler, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin BMalika Larabi, Vanessa Yardley, Philippe M Loiseau, et al.
Plos Neglected Tropical Diseases|March 2, 2021
Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasisAndrew A Voak, Andy Harris, Jose Miguel Coteron-Lopez, et al.
Pageof 36